Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at SEK 1.39T, ahead of Pfizer (SEK 1.23T) and Johnson & Johnson (SEK 1.2T). Figures as of 18 Nov 2026, 14:30 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSEK 1.39T
- Median
- SEK 21.2B
- Combined market value
- SEK 52.18T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 1.39T | SEK 5.21T | SEK 2,945.90 | 1.07% down | 26% up | ||
| 2 | PfizerPFE · Health Care | SEK 1.23T | SEK 1.63T | SEK 286.13 | 1.12% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SEK 1.2T | SEK 6.76T | SEK 2,809.80 | 0.89% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | SEK 873.9B | SEK 12.82T | SEK 14,393.47 | 1.13% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | SEK 856.2B | SEK 3.59T | SEK 1,457.80 | 0.75% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SEK 727.4B | SEK 1.26T | SEK 617.81 | 1.01% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | SEK 664.5B | SEK 2.84T | SEK 1,829.25 | 1.27% down | 2% up | ||
| 8 | NovartisNVS · Health Care | SEK 654.8B | SEK 3.02T | SEK 1,597.21 | 1.31% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SEK 621.6B | SEK 1.16T | SEK 481.97 | 0.27% down | 4% down | ||
| 10 | GSKGSK · Health Care | SEK 609.5B | SEK 998B | SEK 497.88 | 0.53% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | SEK 526.4B | SEK 1.8T | SEK 408.35 | 1.34% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SEK 514.6B | SEK 703B | SEK 220.04 | 0.23% up | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SEK 345.1B | SEK 1.84T | SEK 1,064.70 | 2.55% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 333.9B | SEK 507.4B | SEK 434.89 | 0.38% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SEK 228.6B | SEK 238.4B | SEK 207.94 | 1.40% down | 96% up | ||
| 16 | GrifolsGRFS · Health Care | SEK 136.6B | SEK 59.7B | SEK 87.75 | 1.15% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | SEK 123.4B | SEK 340.1B | SEK 837.09 | 1.38% down | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SEK 100.7B | SEK 401.5B | SEK 698.35 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SEK 94.6B | SEK 1.01T | SEK 9,738.61 | 0.56% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 74.6B | SEK 156.9B | SEK 2,443.80 | 0.15% down | 37% up | ||
| 21 | GenmabGMAB · Health Care | SEK 71.4B | SEK 323.6B | SEK 524.88 | 0.65% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SEK 70.9B | SEK 1.38T | SEK 5,431.80 | 0.67% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SEK 69.3B | SEK 130.9B | SEK 261.83 | 0.39% down | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SEK 42.5B | SEK 211.1B | SEK 1,576.06 | 0.96% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SEK 38.9B | SEK 480B | SEK 4,202.07 | 0.48% up | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SEK 37.3B | SEK 74.8B | SEK 214.75 | 0.52% down | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SEK 31.6B | SEK 51.3B | SEK 613.75 | 1.00% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SEK 30.9B | SEK 45.7B | SEK 274.13 | 3.75% down | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SEK 30.6B | SEK 152.1B | SEK 780.91 | 0.72% down | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 21.5B | SEK 125.4B | SEK 150.39 | 0.61% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | SEK 21.2B | SEK 72.7B | SEK 521.62 | 0.68% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | SEK 16.5B | SEK 179.4B | SEK 2,735.42 | 0.80% down | 28% up | ||
| 33 | InsmedINSM · Health Care | SEK 15.5B | SEK 271.8B | SEK 1,239.09 | 0.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SEK 15.3B | SEK 115.2B | SEK 594.94 | 0.90% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 9B | SEK 61.8B | SEK 437.13 | 2.76% down | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SEK 8B | SEK 252.9B | SEK 5,939.19 | 0.64% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | SEK 7.4B | SEK 31.8B | SEK 163.81 | 0.75% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | SEK 6.8B | SEK 77.7B | SEK 462.14 | 2.32% down | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.7B | SEK 99.7B | SEK 4,290.84 | 0.46% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SEK 6.1B | SEK 72.7B | SEK 1,382.35 | 0.77% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SEK 5.5B | SEK 60B | SEK 2,999.59 | 0.41% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.4B | SEK 61B | SEK 934.96 | 0.40% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 49.9B | SEK 519.59 | 2.82% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | SEK 4.2B | SEK 285.2B | SEK 393.61 | 0.26% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SEK 4.2B | SEK 96.4B | SEK 637.64 | 0.08% down | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SEK 3.1B | SEK 49.3B | SEK 283.18 | 1.49% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 2.1B | SEK 82.2B | SEK 1,185.70 | 8.49% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 2B | SEK 76B | SEK 967.09 | 0.93% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SEK 1.9B | SEK 78B | SEK 712.48 | 1.23% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | SEK 1.5B | SEK 73.1B | SEK 834.80 | 1.81% down | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SEK 1.1B | SEK 40.9B | SEK 298.74 | 2.59% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SEK 938.7M | SEK 83.3B | SEK 104.12 | 4.03% down | 36% down | ||
| 53 | ErascaERAS · Health Care | SEK 721.8M | SEK 49.6B | SEK 141.24 | 8.07% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SEK 636M | SEK 90.6B | SEK 953.87 | 5.60% down | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SEK 607.8M | SEK 86.7B | SEK 3,101.88 | 1.68% down | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SEK 543.8M | SEK 82.7B | SEK 1,267.66 | 0.13% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SEK 381.5M | SEK 49.8B | SEK 884.42 | 2.87% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SEK 308.6M | SEK 46.8B | SEK 427.47 | 3.75% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SEK 169.7M | SEK 66.4B | SEK 979.39 | 2.94% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | SEK 102.4M | SEK 65.1B | SEK 1,603.71 | 2.98% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | SEK 93.1M | SEK 53.9B | SEK 1,277.52 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1681 SEK).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (SEK 1.39T), Pfizer (SEK 1.23T) and Johnson & Johnson (SEK 1.2T) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:30 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of SEK 52.18T as of 18 Nov 2026, 14:30 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.